{"title":"ZOETIS","description":"","products":[{"product_id":"er-bac-r-l5-gold","title":"ER Bac L5 Gold","description":"\u003cp\u003eIndications\n\u003cbr\u003eER Bac® L5 Gold is for vaccination of healthy breeding swine as an aid in preventing erysipelas caused by Erysipelothrix rhusiopathiae and leptospirosis caused by Leptospira canicola, L. grippotyphosa, L. hardjo, L. icterohaemorrhagiae and L. pomona.\u003c\/p\u003e\n\n\u003cp\u003eWhat Is It For?\n\u003cbr\u003eER Bac® L5 Gold is for the vaccination of healthy breeding swine as an aid in preventing erysipelas caused by Erysipelothrix rhusiopathiae and leptospirosis caused by Leptospira canicola, L. grippotyphosa, L. hardjo, L. icterohaemorrhagiae and L. pomona. Leptospira are common agents of reproductive loss in swine. Infection by Leptospira during the second half of pregnancy may cause abortions and stillbirths; late-term abortions are the most important economic effect of leptospirosis.\u003c\/p\u003e\n\n\u003cp\u003eHow Effective Is It?\n\u003cbr\u003eER Bac® L5 Gold has an 18-week duration of immunity following vaccination which has been demonstrated against erysipelas.\n\u003cbr\u003eEfficacy of the fractions of ER Bac® L5 Gold was demonstrated in controlled challenge-of-immunity and immunogenicity tests.\n\u003cbr\u003eThe safety of ER Bac® L5 Gold was demonstrated under field conditions in approximately 1,340 sows and gilts receiving single or multiple doses. No serious systemic or allergic reactions were observed following vaccination.\n\u003cbr\u003eThe antigens have been chemically inactivated and adjuvanted with two adjuvants, including Amphigen®, to enhance immune response.\u003c\/p\u003e\n\n\u003cp\u003eDosage and Administration\n\u003cbr\u003eShake well. Aseptically administer 2 mL intramuscularly.\u003c\/p\u003e\n\n\u003cp\u003eHealthy swine should receive two doses three to five weeks apart, with the second dose administered two to four weeks prior to breeding. Healthy gilts, however, should receive the second dose as near as possible to 14 days prior to breeding.\u003c\/p\u003e\n\n\u003cp\u003eRevaccination with a single dose is recommended prior to subsequent breedings. Boars should be revaccinated semiannually.\u003c\/p\u003e","brand":"ZOETIS","offers":[{"title":"50","offer_id":48057245499621,"sku":null,"price":30.38,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0776\/2899\/7861\/files\/ERBac-L5GoldBottle100mLProductShotPNG.png?v=1763130519"},{"product_id":"er-bac-r-plus","title":"ER Bac Plus","description":"\u003cp\u003eHow Effective Is It?\n\u003cbr\u003eThis product has been shown to be efficacious in healthy animals. A protective immune response may not be elicited if animals are incubating an infectious disease, are malnourished or parasitized, are stressed due to shipment or environmental conditions, are otherwise immunocompromised, or the vaccine is not administered in accordance with label directions.\u003c\/p\u003e\n\n\u003cp\u003eDosage and Administration\n\u003cbr\u003eShake well. Aseptically administer 2 mL intramuscularly.\n\u003cbr\u003eHealthy swine 3 weeks of age or older should receive two 2-mL doses administered 3-4 weeks apart. Semiannual revaccination with a single dose is recommended.\u003c\/p\u003e","brand":"ZOETIS","offers":[{"title":"250","offer_id":48057245630693,"sku":null,"price":84.17,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0776\/2899\/7861\/files\/ERBacPlusProductShot500mLBottleProductShotTIFF_1.jpg?v=1763130431"},{"product_id":"farrowsure-r-gold","title":"Farrowsure GOLD","description":"\u003cp\u003eIndications\n\u003cbr\u003eFarrowsure® GOLD and Farrowsure® GOLD B are approved for use in healthy breeding swine as an aid in preventing reproductive failure caused by porcine parvovirus (PPV); erysipelas caused by Erysipelothrix rhusiopathiae; and leptospirosis caused by Leptospira canicola, L. grippotyphosa, L. hardjo, L. icterohaemorrhagiae and L. pomona.\n\u003cbr\u003eFarrowsure GOLD B helps protect against L. bratislava.\u003c\/p\u003e\n\n\u003cp\u003eWhat Is It For?\n\u003cbr\u003eFarrowsure® GOLD and Farrowsure® GOLD B help protect against some of the leading causes of reproductive failure in swine — parvovirus, leptospirosis and erysipelas – which are costly breeding herd diseases.\u003c\/p\u003e\n\n\u003cp\u003eFarrowsure GOLD and Farrowsure GOLD B are approved for use in healthy breeding swine as an aid in preventing reproductive failure caused by porcine parvovirus (PPV); erysipelas caused by Erysipelothrix rhusiopathiae; and leptospirosis caused by Leptospira canicola, L. grippotyphosa, L. hardjo, L. icterohaemorrhagiae and L. pomona. Farrowsure GOLD B helps protect against L. bratislava.\u003c\/p\u003e\n\n\u003cp\u003eHow Effective Is It?\n\u003cbr\u003eFarrowsure® GOLD and Farrowsure® GOLD B contain two adjuvants, including Amphigen®, which enhances the immune response using the animal’s natural defense system to fight disease.\u003c\/p\u003e\n\n\u003cp\u003eFarrowsure GOLD and Farrowsure GOLD B provide clinically demonstrated 18-week post-vaccination duration of immunity against erysipelas caused by Erysipelothrix rhusiopathiae.1\n\u003cbr\u003eThree field safety studies involving 205 prebreeding gilts and 406 gestating sows and gilts indicated that two doses of Farrowsure GOLD B, in combination with FluSure XP®, can be safely administered to prebreeding gilts and that a dose can be safely given to pregnant sows as late as two to four weeks prior to farrowing (73 to 101 days of gestation).2-4\n\u003cbr\u003eIn a field safety study conducted in prebreeding gilts, injection site reactions were rare.3\n\u003cbr\u003eResults were similar in gestating sows and gilts: When administered according to label directions to pregnant sows and gilts at two to four weeks prior to farrowing, reactions were minimal in number, of little consequence in severity and transient in duration.2,3\u003c\/p\u003e\n\n\u003cp\u003eDosage and Administration\n\u003cbr\u003eShake well. Aseptically administer 2 mL intramuscularly.\u003c\/p\u003e\n\n\u003cp\u003eHealthy swine should receive two doses three to five weeks apart, with the second dose administered two to four weeks prior to breeding. Healthy gilts, however, should receive the second dose as near as possible to 14 days prior to breeding.\u003c\/p\u003e\n\n\u003cp\u003eRevaccination with a single dose is recommended prior to subsequent breedings. Boars should be revaccinated semiannually.\u003c\/p\u003e\n\n\u003cp\u003eReferences\n\u003cbr\u003e1 Data on file, Study Report No. 3121R-60-05-339, Zoetis Inc.\n\u003cbr\u003e2 Data on file, Study Report No. 3427R-60-06-396, Zoetis Inc.\n\u003cbr\u003e3 Data on file, Study Report No. 3427R-60-06-397, Zoetis Inc.\n\u003cbr\u003e4 Data on file, Study Report No. 3427R-60-06-398, Zoetis Inc.\u003c\/p\u003e","brand":"ZOETIS","offers":[{"title":"50","offer_id":48057246253285,"sku":null,"price":54.57,"currency_code":"USD","in_stock":true},{"title":"250","offer_id":48057246286053,"sku":null,"price":273.81,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0776\/2899\/7861\/files\/FarrowSureGoldandFarrowSureGoldBGroupProductShotPNG_4b550f84-3d6f-430d-b529-05e2e5b5438b.png?v=1763130293"},{"product_id":"farrowsure-r-gold-b","title":"Farrowsure GOLD B","description":"\u003cp\u003eIndications\n\u003cbr\u003eFarrowsure® GOLD and Farrowsure® GOLD B are approved for use in healthy breeding swine as an aid in preventing reproductive failure caused by porcine parvovirus (PPV); erysipelas caused by Erysipelothrix rhusiopathiae; and leptospirosis caused by Leptospira canicola, L. grippotyphosa, L. hardjo, L. icterohaemorrhagiae and L. pomona.\n\u003cbr\u003eFarrowsure GOLD B helps protect against L. bratislava.\u003c\/p\u003e\n\n\u003cp\u003eWhat Is It For?\n\u003cbr\u003eFarrowsure® GOLD and Farrowsure® GOLD B help protect against some of the leading causes of reproductive failure in swine — parvovirus, leptospirosis and erysipelas – which are costly breeding herd diseases.\u003c\/p\u003e\n\n\u003cp\u003eFarrowsure GOLD and Farrowsure GOLD B are approved for use in healthy breeding swine as an aid in preventing reproductive failure caused by porcine parvovirus (PPV); erysipelas caused by Erysipelothrix rhusiopathiae; and leptospirosis caused by Leptospira canicola, L. grippotyphosa, L. hardjo, L. icterohaemorrhagiae and L. pomona. Farrowsure GOLD B helps protect against L. bratislava.\u003c\/p\u003e\n\n\u003cp\u003eHow Effective Is It?\n\u003cbr\u003eFarrowsure® GOLD and Farrowsure® GOLD B contain two adjuvants, including Amphigen®, which enhances the immune response using the animal’s natural defense system to fight disease.\u003c\/p\u003e\n\n\u003cp\u003eFarrowsure GOLD and Farrowsure GOLD B provide clinically demonstrated 18-week post-vaccination duration of immunity against erysipelas caused by Erysipelothrix rhusiopathiae.1\n\u003cbr\u003eThree field safety studies involving 205 prebreeding gilts and 406 gestating sows and gilts indicated that two doses of Farrowsure GOLD B, in combination with FluSure XP®, can be safely administered to prebreeding gilts and that a dose can be safely given to pregnant sows as late as two to four weeks prior to farrowing (73 to 101 days of gestation).2-4\n\u003cbr\u003eIn a field safety study conducted in prebreeding gilts, injection site reactions were rare.3\n\u003cbr\u003eResults were similar in gestating sows and gilts: When administered according to label directions to pregnant sows and gilts at two to four weeks prior to farrowing, reactions were minimal in number, of little consequence in severity and transient in duration.2,3\u003c\/p\u003e\n\n\u003cp\u003eDosage and Administration\n\u003cbr\u003eShake well. Aseptically administer 2 mL intramuscularly.\u003c\/p\u003e\n\n\u003cp\u003eHealthy swine should receive two doses three to five weeks apart, with the second dose administered two to four weeks prior to breeding. Healthy gilts, however, should receive the second dose as near as possible to 14 days prior to breeding.\u003c\/p\u003e\n\n\u003cp\u003eRevaccination with a single dose is recommended prior to subsequent breedings. Boars should be revaccinated semiannually.\u003c\/p\u003e\n\n\u003cp\u003eReferences\n\u003cbr\u003e1 Data on file, Study Report No. 3121R-60-05-339, Zoetis Inc.\n\u003cbr\u003e2 Data on file, Study Report No. 3427R-60-06-396, Zoetis Inc.\n\u003cbr\u003e3 Data on file, Study Report No. 3427R-60-06-397, Zoetis Inc.\n\u003cbr\u003e4 Data on file, Study Report No. 3427R-60-06-398, Zoetis Inc.\u003c\/p\u003e","brand":"ZOETIS","offers":[{"title":"50","offer_id":48057246482661,"sku":null,"price":105.84,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0776\/2899\/7861\/files\/FarrowSureGoldandFarrowSureGoldBGroupProductShotPNG.png?v=1763130183"},{"product_id":"fostera-r-gold-pcv","title":"FOSTERA GOLD PCV","description":"\u003cp\u003eIndications: For the vaccination of healthy pigs 3 days of age or older against porcine circovirus 2 (PCV2).\u003c\/p\u003e\n\n\u003cp\u003eDosage and Administration\n\u003cbr\u003eShake well\n\u003cbr\u003eSingle-dose protocol: Administer a single 2-mL dose intramuscularly to healthy pigs 3 weeks of age or older.\n\u003cbr\u003eFlexible, two-dose protocol: Also may be given as two 1-mL doses administered intramuscularly three weeks apart to pigs 3 days of age* or older.\n\u003cbr\u003eThe optimal choice of the dosing regimen, including age at time of vaccination, will depend on farm circumstances.\n\u003cbr\u003e* Field experience with PCV2 vaccines indicates that waiting until 3 weeks of age to initiate a split-dose regimen may yield a better immune response, even though the vaccine is safe when given at a younger age.\u003c\/p\u003e\n\n\u003cp\u003eHow Effective Is It?\n\u003cbr\u003eFostera® Gold PCV contains PCV2a and PCV2b and has been shown to be effective for the vaccination of healthy pigs against PCV2, including PCV2 viremia, shedding of virus in feces, lymphoid colonization and lymphoid depletion.\u003c\/p\u003e\n\n\u003cp\u003eHow Does It Work?\n\u003cbr\u003eA safe, smooth vaccine. Fostera® Gold PCV was developed with the unique and smooth MetaStim® adjuvant that stimulates both cell-mediated and antibody-based immunity with minimal post-vaccination reactions.8\n\u003cbr\u003eContinued productivity at the finishing stage. PCV2 virus change and depressed immunity are unwanted surprises in pork production, especially at the finishing stage, risking pig health and productivity as well as farm profitability.\u003c\/p\u003e\n\n\u003cp\u003eReferences\n\u003cbr\u003e1. Firth C, Charleston MA, Duffy S, Shapiro B, Holmes EC. Insights into the Evolutionary History of an Emerging Livestock Pathogen: Porcine Circovirus 2. J Virol. 2009;83(24):12813-12821.\n\u003cbr\u003e2. Data on file, Study Report No. B822R-US-14-325, Zoetis Inc.\n\u003cbr\u003e3. Data on file, Study Report No. B822R-US-16-582, Zoetis Inc.\n\u003cbr\u003e4. Data on file, Study Report No. B825R-US-16-667, Zoetis Inc.\n\u003cbr\u003e5. Data on file, Study Report No. B822R-US-15-557, Zoetis Inc.\n\u003cbr\u003e6. Data on file, Study Report No. B824R-US-15-451, Zoetis Inc.\n\u003cbr\u003e7. Data on file, Study Report No. B824R-US-13-118, Zoetis Inc.\n\u003cbr\u003e8. Data on file, Study Report No. B921R-US-16-609, Zoetis Inc.\n\u003cbr\u003e9. Data on file, Study Report No. B921R-US-20-992, Zoetis Inc\u003c\/p\u003e","brand":"ZOETIS","offers":[{"title":"50","offer_id":48057246941413,"sku":null,"price":47.1,"currency_code":"USD","in_stock":true},{"title":"250","offer_id":48057267192037,"sku":null,"price":235.38,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0776\/2899\/7861\/files\/FosteraGoldPCVBottleProductShot100ml_1.jpg?v=1763130027"},{"product_id":"fostera-r-gold-pcv-mh","title":"Fostera Gold PCV MH","description":"\u003cp\u003eIndications\n\u003cbr\u003eFostera® Gold PCV MH is for the vaccination of healthy pigs, including pregnant sows and gilts, 3 days of age or older against porcine circovirus Type 2 (PCV2) and respiratory disease due to Mycoplasma hyopneumoniae (Mhp).\u003c\/p\u003e\n\n\u003cp\u003eWhat is it for?\n\u003cbr\u003eFor the vaccination of healthy pigs, including pregnant sows and gilts, 3 days of age and older against porcine circovirus Type 2 (PCV2) and respiratory disease due to Mycoplasma hyopneumoniae (Mhp).\u003c\/p\u003e\n\n\u003cp\u003eDosage and administration\n\u003cbr\u003eSingle dose protocol: Administer a single 2 mL dose intramuscularly to healthy pigs 3 weeks of age or older.\u003c\/p\u003e\n\n\u003cp\u003eTwo dose protocol: May also be given as two 1 mL doses administered intramuscularly three weeks apart to pigs 3 days of age or older.\u003c\/p\u003e\n\n\u003cp\u003eHow does it work?\n\u003cbr\u003eFostera® Gold PCV MH is a bivalent vaccine containing two porcine circovirus Type 2 (PCV2) genotypes — PCV2a and PCV2b — for the broadest antigenic and longest-lasting protection against PCV2a, PCV2b and Mycoplasma hyopneumoniae (Mhp) with cross protection, shown in a study, against PCV2d.1-10\u003c\/p\u003e\n\n\u003cp\u003eReferences\n\u003cbr\u003e1. Data on file, Study Report No. B822R-US-14-325, Zoetis Inc.\n\u003cbr\u003e2. Data on file, Study Report No. B822R-US-16-582, Zoetis Inc.\n\u003cbr\u003e3. Data on file, Study Report No. B825R-US-16-667, Zoetis Inc.\n\u003cbr\u003e4. Data on file, Study Report No. B822R-US-15-557, Zoetis Inc.\n\u003cbr\u003e5. Data on file, Study Report No. B824R-US-15-451, Zoetis Inc.\n\u003cbr\u003e6. Data on file, Study Report No. B824R-US-13-118, Zoetis Inc.\n\u003cbr\u003e7. Data on file, Study Report No. B822R-US-15-544, Zoetis Inc.\n\u003cbr\u003e8. Data on file, Study Report No. B822R-US-16-622, Zoetis Inc.\n\u003cbr\u003e9. Data on file, Study Report No. B824R-US-15-505, Zoetis Inc.\n\u003cbr\u003e10. Um, H, et al., Vaccines, 2021\u003c\/p\u003e","brand":"ZOETIS","offers":[{"title":"50","offer_id":48057267355877,"sku":null,"price":53.8,"currency_code":"USD","in_stock":true},{"title":"250","offer_id":48057267388645,"sku":null,"price":269.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0776\/2899\/7861\/files\/FosteraGoldPCVMHBottleProductShot100ml_1.jpg?v=1763129966"},{"product_id":"fostera-r-prrs","title":"FOSTERA PRRS","description":"\u003cp\u003eIndications:\n\u003cbr\u003eThis product has been shown to be effective for the vaccination of healthy swine one day of age or older in porcine reproductive and respiratory syndrome (PRRS) virus-positive herds against reproductive disease caused by PRRS virus.1\u003c\/p\u003e\n\n\u003cp\u003eA duration of immunity of at least 19 weeks has been demonstrated against reproductive disease in swine vaccinated pre-breeding.\n\u003cbr\u003eA duration of immunity of at least 26 weeks has been demonstrated against respiratory disease.\u003c\/p\u003e\n\n\u003cp\u003eWhat Is It For?\n\u003cbr\u003eFostera® PRRS has shown to be effective for the vaccination of healthy swine 1 day of age or older in PRRS virus-positive herds against respiratory and reproductive disease caused by PRRS virus.\u003c\/p\u003e\n\n\u003cp\u003eHow Effective Is It?\n\u003cbr\u003eFostera® PRRS is labeled to help combat the impacts of both reproductive and respiratory diseases, helping protect both the breeding herd and growing pigs.\u003c\/p\u003e\n\n\u003cp\u003eThe earliest immune response. Fostera® PRRS is the only commercially available PRRS vaccine labeled for administration as early as one day of age.\n\u003cbr\u003eThe long-lasting immune response. Fostera® PRRS carries a duration of immunity (DOI) claim of at least 26 weeks against respiratory disease. Fostera® PRRS also carries a DOI of at least 19 weeks against reproductive disease.\u003c\/p\u003e\n\n\u003cp\u003eFostera PRRS helps deliver:\n\u003cbr\u003e-More pigs to market: Fostera® PRRS helps deliver more live pigs by helping prevent reproductive disease caused by PRRSV.7\n\u003cbr\u003e-More pounds of pork to market: Fostera® PRRS was shown to help growing pigs get to marketing faster with improved average daily gain (ADG) in the face of a PRRSV challenge.2-6\u003c\/p\u003e\n\n\u003cp\u003eDosage and Administration\n\u003cbr\u003eAseptically rehydrate the freeze-dried vaccine with the sterile diluent provided. Shake well and aseptically administer a single 2-mL dose intramuscularly. Efficacy has not been demonstrated in seropositive piglets. In young pigs, revaccinate after maternally derived antibodies to PRRS have declined. Safety of this product has been demonstrated when sows or gilts are vaccinated prior to breeding or at any stage of pregnancy. Protection against reproductive disease, however, was demonstrated when animals were vaccinated six weeks prior to breeding. Consult your veterinarian for appropriate use and timing of vaccination.\u003c\/p\u003e\n\n\u003cp\u003eReferences\n\u003cbr\u003e1. Data on file, Study Report No. 3127R-60-11-961, Zoetis Inc.\n\u003cbr\u003e2. Data on file, Study Report No. 3127R-60-10-890, Zoetis Inc.\n\u003cbr\u003e3. Data on file, Study Report No. 3121R-60-10-909, Zoetis Inc.\n\u003cbr\u003e4. Data on file, Study Report No. B822R-US-15-506, Zoetis Inc.\n\u003cbr\u003e5. Data on file, Study Report No. ORPORK2022, Zoetis Inc.\n\u003cbr\u003e6. Data on file, Study Report No. N-3335772\/2013.2, Zoetis Inc.\n\u003cbr\u003e7. Data on file, Study Report No. 3127R-60-11-988, Zoetis Inc.\u003c\/p\u003e","brand":"ZOETIS","offers":[{"title":"50","offer_id":48057267421413,"sku":null,"price":42.97,"currency_code":"USD","in_stock":true},{"title":"250","offer_id":48057267454181,"sku":null,"price":214.96,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0776\/2899\/7861\/files\/FosteraPRRS250-DoseFamilyProductShot500mLTIFF_1.jpg?v=1763129795"},{"product_id":"litterguard-r","title":"Litterguard","description":"\u003cp\u003eIndications\n\u003cbr\u003eFor vaccination of healthy pregnant sows and gilts for passive transfer of protective maternal antibodies to their piglets to help protect against neonatal diarrhea caused by beta toxin produced by C. perfringens Type C and enterotoxigenic strains of E. coli-producing heat-labile toxin or having the K99, K88, 987P or F41 adherence factors.\u003c\/p\u003e\n\n\u003cp\u003eWhat Is It For?\n\u003cbr\u003eLitterguard helps protect against illness caused by enterotoxigenic strains of Escherichia coli (E. coli) having the K99, K88, 987P or F41 adherence factors. It also helps protect against neonatal diarrhea caused by beta toxin produced by Clostridium perfringens Type C.\u003c\/p\u003e\n\n\u003cp\u003eDosage and Administration \n\u003cbr\u003eGeneral directions: Shake well. Aseptically administer 2 mL intramuscularly or subcutaneously.\n\u003cbr\u003ePrimary vaccination: Healthy pregnant swine should receive two doses administered three weeks apart during the last half of pregnancy. The second dose should be given at least two weeks before farrowing.\n\u003cbr\u003eRevaccination: Pregnant swine should be revaccinated with a single dose at least two weeks before each subsequent farrowing.\n\u003cbr\u003eGood animal husbandry and herd health management practices should be employed.\u003c\/p\u003e\n\n\u003cp\u003eHow Does It Work?\n\u003cbr\u003eLitterguard contains a sterile adjuvant to help enhance the immune response by using the animal's natural defense system to fight disease.\u003c\/p\u003e","brand":"ZOETIS","offers":[{"title":"50","offer_id":48057267519717,"sku":null,"price":54.72,"currency_code":"USD","in_stock":true},{"title":"250","offer_id":48057267552485,"sku":null,"price":268.51,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0776\/2899\/7861\/files\/LitterGuardBottle50-Doses100mLProductShotPNG.png?v=1763129630"},{"product_id":"respisure-one-r","title":"RespiSure ONE","description":"\u003cp\u003eIndications\n\u003cbr\u003eFor the vaccination of healthy swine and newborn pigs 1 day of age and older as an aid effective against chronic pneumonia caused by Mhp.\u003c\/p\u003e\n\n\u003cp\u003eRespiSure-ONE® allows for vaccination for mycoplasmal pneumonia when you process baby pigs. This is important because Mhp may infect pigs within the first three weeks of life.1,2 When your goal is healthy herds, RespiSure-ONE provides early, easy and effective protection from the start.\u003c\/p\u003e\n\n\u003cp\u003eWhat Is It For?\n\u003cbr\u003eFor the vaccination of healthy swine and newborn pigs 1 day of age and older effective against chronic pneumonia caused by Mhp.\u003c\/p\u003e\n\n\u003cp\u003eHow Effective Is It?\n\u003cbr\u003eWhen challenged, pigs vaccinated at 1 day of age showed reduced lung lesions, colonization and shedding.3 RespiSure-ONE® is demonstrated safe for use in 1-day-old pigs.3 Duration of immunity in 1-day-old pigs has not been established.\u003c\/p\u003e\n\n\u003cp\u003eReduction in severity of Mhp colonization. Pigs vaccinated at 1 day of age had an 85% reduction in the number of mycoplasma bacterial cells in bronchial swab samples when compared with nonvaccinated controls.3\n\u003cbr\u003eReduction of Mhp shedding. At 17, 21 and 24 days after challenge, the percentage of vaccinates of RespiSure-ONE that shed Mhp was less than the control pigs.3\n\u003cbr\u003eTwenty-five-week duration of immunity. Pigs vaccinated at 3 to 8 days of age and challenged 25 weeks later had a 95% reduction in lung lesions and a significantly superior serological response, compared with nonvaccinated controls.4\n\u003cbr\u003eImproved immune response. Amphigen®, the adjuvant in RespiSure-ONE, helps provide a duration of immunity with a high degree of safety, ease of use and syringeability.\u003c\/p\u003e\n\n\u003cp\u003eDosage and Administration\n\u003cbr\u003eShake well. Aseptically administer a 2-mL dose intramuscularly. RespiSure-ONE® also may be given as two 1-mL doses administered two weeks apart.\u003c\/p\u003e\n\n\u003cp\u003eReferences\n\u003cbr\u003e1. Fano E, Pijoan C, Dee S, Deen J. Effect of Mycoplasma hyopneumoniae colonization at weaning on disease severity in growing pigs. Can J Vet Res. 2007;71(3):195-200.\n\u003cbr\u003e2. Sibila M, Nofrarias M, Lopez-Soria S, et al. Exploratory field study on Mycoplasma hyopneumoniae infection in suckling pigs. Vet Microbiol. 2007;121:352-356.\n\u003cbr\u003e3. Data on file, Study Report No. 3127R-60-07-552, Zoetis Inc.\n\u003cbr\u003e4. Data on file, Study Report Nos. 3121C-60-99-227 and 3121C-60-99-223, Zoetis Inc.\n\u003cbr\u003e5. Connor JF. Early pig vaccination disease breakthrough. National Hog Farmer. 2009;27.\u003c\/p\u003e","brand":"ZOETIS","offers":[{"title":"50","offer_id":48057267945701,"sku":null,"price":34.78,"currency_code":"USD","in_stock":true},{"title":"250","offer_id":48057267978469,"sku":null,"price":163.65,"currency_code":"USD","in_stock":true},{"title":"500","offer_id":48057268011237,"sku":null,"price":321.2,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0776\/2899\/7861\/files\/RespiSure1OneGroupProductShotPNG.png?v=1763129227"}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0776\/2899\/7861\/collections\/Zoetis_logo_svg.png?v=1767202341","url":"https:\/\/www.passionforpigs.com\/collections\/boehringer-ingelheim-copy.oembed","provider":"Passion for Pigs Veterinary Service","version":"1.0","type":"link"}